ReleaseWire Connect

This report reviews the performance and asset allocations of HNWIs and ultra-HNWIs in Singapore. It also includes an evaluation of the local wealth management market.

Follicular Thyroid Cancer Pipeline Review, H2 2014 report provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Follicular Thyroid Cancer and special features on late-stage and discontinued projects.

Age Related Memory Impairment Pipeline Review, H2 2014 report provides comprehensive information on the therapeutic development for Age Related Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Memory Impairment and special features on late-stage and discontinued projects.

This is a full business plan based on the launch of an illustrative Mobile Virtual Network Operator (MVNO) known as Contendus. The plan covers all aspects of the company launch plan including market assessment, funding requirements, financial analysis, market segmentation and product differentiation. Also included is go-to-market plan, distribution and replenishment plans, comparison of MVNO's and more. The major benefit of this report is to assist in the development of an MVNO launch and to help validate existing plans.

This is a full business plan based on the launch of an illustrative Mobile Virtual Network Operator (MVNO) known as Contendus. The plan covers all aspects of the company launch plan including market assessment, funding requirements, financial analysis, market segmentation and product differentiation. Also included is go-to-market plan, distribution and replenishment plans, comparison of MVNO's and more. The major benefit of this report is to assist in the development of an MVNO launch and to help validate existing plans.

While LTE and LTE-Advanced deployments are still underway, wireless carriers and vendors have already embarked on R&D initiatives to develop so-called "5G" technology, with a vision of commercialization by 2020.

Given the increasing prevalence of expensive household goods, cars and consumer electronics, insurance has become an unavoidable and often necessary cost in modern life. Mobile phones, and smartphones in particular are no exception to this trend.

Machine-to-machine (M2M) communications has historically represented the integration of microprocessors, microcontrollers and sensors with communications, monitoring and control systems to improve efficiencies and effectiveness of business operations. The introduction of the Internet of Things (IoT) is taking M2M to entirely new level as applications are rapidly expanding beyond traditional boundaries. One of the anticipated impacts of IoT will be rapid growth of consumer oriented M2M applications and increased involvement of consumers as a key element of the M2M value chain.

Cloud services have already caused a major transformation in technologies and a shift in business operations focus that has affected everything from ERP to datacenter planning. One of the crucial aspects of the next phases in the evolution of Cloud Services will be the extent to which various players can deal with the anticipated scope of many supplier/customer relationships and associated scale of data exchange and transactions.

Francisella Tularensis Infections - Pipeline Review, H2 2014 report provides comprehensive information on the therapeutic development for Francisella Tularensis Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Francisella Tularensis Infections and special features on late-stage and discontinued projects.